RLMD Stock Surges: 2026 Forecast to $10?
RLMD stock jumps on bladder cancer data and $160M raise. Check latest RLMD stock price, technical analysis, earnings, forecast, and is RLMD stock a buy now. Introduction RLMD stock has grabbed attention with a sharp rise. Relmada Therapeutics focuses on treatments for central nervous system disorders and now oncology like bladder cancer. Investors watch RLMD … Read more